Trial Profile
The Effects of Co-administration of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors KineMed
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 26 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 26 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.